Kutki for Fever Management

Research suggests that Kutki (Picrorhiza kurroa) has a longstanding traditional role in fever management, with its active compounds — particularly picrosides I and II and the purified extract Picroliv — identified as potentially relevant to this use through proposed mechanisms such as anti-inflammatory activity via NF-κB inhibition. The available evidence consists primarily of traditional use documentation, ethnomedicinal records, bioavailability studies, and one review of the broader pharmacological literature, with no clinical trials or randomized controlled studies specifically examining Kutki's effects on fever in humans. Studies indicate that Ayurvedic formulations incorporating Kutki, such as Jwarahara Kwatha Choornam, have been standardized for traditional fever applications, though this standardization work does not itself constitute efficacy evidence. Overall, while the direction of the existing literature is consistently supportive of the traditional claim, the evidence base relies heavily on historical use and preliminary mechanistic research rather than controlled human trials, leaving the clinical picture largely unestablished.